Quality of Life Reported by Survivors After Hospitalization for Middle East Respiratory Syndrome (MERS)
Overview
Authors
Affiliations
Introduction: Data are lacking on impact of Middle East Respiratory Syndrome (MERS) on health-related quality of life (HRQoL) among survivors.
Methods: We conducted a cross-sectional survey of MERS survivors who required hospitalization in Saudi Arabia during 2016-2017, approximately 1 year after diagnosis. The Short-Form General Health Survey 36 (SF-36) was administered by telephone interview to assess 8 quality of life domains for MERS survivors and a sample of survivors of severe acute respiratory infection (SARI) without MERS. We compared mean SF-36 scores of MERS and non-MERS SARI survivors using independent t-test, and compared categorical variables using chi-square test. Adjusted analyses were performed using multiple linear regression.
Results: Of 355 MERS survivors, 83 were eligible and 78 agreed to participate. MERS survivors were younger than non-MERS SARI survivors (mean ± SD): (44.9 years ±12.9) vs (50.0 years ±13.6), p = 0.031. Intensive care unit (ICU) admissions were similar for MERS and non-MERS SARI survivors (46.2% vs. 57.1%), p = 0.20. After adjusting for potential confounders, there were no significant differences between MERS and non-MERS SARI survivors in physical component or mental component summary scores. MERS ICU survivors scored lower than MERS survivors not admitted to an ICU for physical function (p = 0.05), general health (p = 0.01), vitality (p = 0.03), emotional role (p = 0.03) and physical component summary (p < 0.02).
Conclusions: Functional scores were similar for MERS and non-MERS SARI survivors. However, MERS survivors of critical illness reported lower quality of life than survivors of less severe illness. Efforts are needed to address the long-term medical and psychological needs of MERS survivors.
Predictors of Functional Impairment in Severe COVID-19 Patients Two Months After Discharge.
El Kik A, Eid H, Nassim N, Hoyek K, Riachy A, Habr B Ther Adv Pulm Crit Care Med. 2024; 19:29768675241305102.
PMID: 39713096 PMC: 11660074. DOI: 10.1177/29768675241305102.
Koech M, Mwangi J, Kithaka B, Kimaru S, Kusu N, Munyi L Heliyon. 2024; 10(9):e30165.
PMID: 38720711 PMC: 11076907. DOI: 10.1016/j.heliyon.2024.e30165.
Wright G, Senthil K, Zadeh-Kochek A, Au J, Zhang J, Huang J BMJ Open. 2024; 14(3):e076797.
PMID: 38508629 PMC: 10961539. DOI: 10.1136/bmjopen-2023-076797.
Laporte L, Chavez A, Ranzani O, Caldas J, da Hora Passos R, Ramos J Einstein (Sao Paulo). 2024; 22(spe1):eRW0352.
PMID: 38477798 PMC: 11730323. DOI: 10.31744/einstein_journal/2024RW0352.
Laguarta-Val S, Varillas-Delgado D, Lizcano-Alvarez A, Molero-Sanchez A, Melian-Ortiz A, Cano-de-la-Cuerda R J Clin Med. 2024; 13(4).
PMID: 38398348 PMC: 10889227. DOI: 10.3390/jcm13041035.